Antibodies, humanized antibodies, resurfaced antibodies, antibody fragments, derivatized antibodies, and conjugates of same with cytotoxic agents, which specifically bind to, and inhibit, insulin-like growth factor-I receptor, antagonize the effects of IGF-I, IGF-II and serum on the growth and survival...http://www.google.fr/patents/US20030235582?utm_source=gb-gplus-shareBrevet US20030235582 - Anti-IGF-I receptor antibody
Numéro de demande: 10/170,390 Numéro de publication: US 2003/0235582 A1 Date de dépôt: 14 juin 2002 Brevet délivré: US7538195 ( Date de délivrance 26 mai 2009)